Olympus Corp Company Profile (OTCMKTS:OCPNY)

About Olympus Corp (OTCMKTS:OCPNY)

Olympus Corp logoOlympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company's segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company's Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products. Its Scientific Solutions Business manufactures and sells biological microscopes, industrial microscopes, industrial endoscopes, non-destructive testing equipment and other products. Its Imaging Business manufactures and sells digital cameras, voice recorders and other products. Its Others Business manufactures and sells biomedical materials, conducts system development and other business activities. Its technologies include optical technologies, electronic imaging technologies, precision technologies and biological based technologies. It has a service network consisting of over 200 sites on approximately six continents.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:OCPNY
  • CUSIP: N/A
  • Web: www.olympus-global.com
Capitalization:
  • Market Cap: $12.91 billion
  • Outstanding Shares: 342,236,000
Average Prices:
  • 50 Day Moving Avg: $37.91
  • 200 Day Moving Avg: $36.17
  • 52 Week Range: $31.50 - $42.02
P/E:
  • Trailing P/E Ratio: 18.36
  • Foreward P/E Ratio: 38.09
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $6.73 billion
  • Price / Sales: 1.92
  • Book Value: $11.28 per share
  • Price / Book: 3.34
Profitability:
  • EBIDTA: $1.17 billion
  • Net Margins: 8.13%
  • Return on Equity: 17.99%
  • Return on Assets: 6.89%
Debt:
  • Debt-to-Equity Ratio: 0.63%
  • Current Ratio: 1.85%
  • Quick Ratio: 1.39%
Misc:
  • Average Volume: 5,267 shs.
  • Beta: 1
 

Frequently Asked Questions for Olympus Corp (OTCMKTS:OCPNY)

What is Olympus Corp's stock symbol?

Olympus Corp trades on the OTCMKTS under the ticker symbol "OCPNY."

How were Olympus Corp's earnings last quarter?

Olympus Corp (OTCMKTS:OCPNY) released its quarterly earnings data on Friday, February, 7th. The company reported $0.42 earnings per share for the quarter. Olympus Corp had a return on equity of 17.99% and a net margin of 8.13%. View Olympus Corp's Earnings History.

Who are some of Olympus Corp's key competitors?

How do I buy Olympus Corp stock?

Shares of Olympus Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Olympus Corp stock cost?

One share of Olympus Corp stock can currently be purchased for approximately $37.71.

Analyst Ratings

Consensus Ratings for Olympus Corp (OTCMKTS:OCPNY) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Olympus Corp (OTCMKTS:OCPNY)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Olympus Corp (OTCMKTS:OCPNY)
Earnings by Quarter for Olympus Corp (OTCMKTS:OCPNY)
Earnings History by Quarter for Olympus Corp (OTCMKTS:OCPNY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2014Q4$0.42ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Olympus Corp (OTCMKTS:OCPNY)
Current Year EPS Consensus Estimate: $1.13 EPS
Next Year EPS Consensus Estimate: $0.99 EPS

Dividends

Dividend History for Olympus Corp (OTCMKTS:OCPNY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Olympus Corp (OTCMKTS:OCPNY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Olympus Corp (OTCMKTS:OCPNY)
Latest Headlines for Olympus Corp (OTCMKTS:OCPNY)
Source:
DateHeadline
americanbankingnews.com logoOlympus Corp (OCPNY) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - May 14 at 8:58 PM
americanbankingnews.com logoOlympus Corp (OCPNY) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - May 9 at 7:34 AM
finance.yahoo.com logoETFs with exposure to Olympus Corp. : April 7, 2017
finance.yahoo.com - April 7 at 7:24 PM
latimes.com logoOlympus executives plead the 5th when questioned about the deadly outbreaks tied to the company's medical scopes
www.latimes.com - December 19 at 10:04 AM
investopedia.com logoBoston Scientific Unveils Improved Endoclip (BSX)
www.investopedia.com - October 19 at 11:38 AM
latimes.com logoCongressman calls on Japanese prosecutors to probe Olympus over scope infections
www.latimes.com - September 1 at 6:52 PM
finance.yahoo.com logoOlympus Eyes M&A in Ongoing Recovery
finance.yahoo.com - July 20 at 9:30 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Honda Motor, Toyota Motor, Canon and Olympus
finance.yahoo.com - July 14 at 9:30 AM
finance.yahoo.com logoOlympus Corporation of the Americas Enters Into US And Canada Distribution Agreement With Arc Medical Design Ltd, A Subsidiary Of Norgine For ENDOCUFF VISION®
finance.yahoo.com - May 6 at 8:00 AM
thestreet.com logo[video]Olympus Teams Up With Sony for Surgical Big Screen TV
www.thestreet.com - April 9 at 10:26 PM
latimes.com logoOlympus sought price hike for UCLA amid superbug outbreak
www.latimes.com - March 25 at 6:04 AM
forbes.com logoWhistleblower Delivers A Triple Whammy To Olympus; More Companies Might Get Hit
www.forbes.com - March 4 at 5:45 PM
latimes.com logoOlympus to pay at least $635 million to settle kickback and bribery cases
www.latimes.com - March 1 at 2:20 PM
bloomberg.com logoOlympus Will Pay $646 Million to End Kickback, Bribe Probes
www.bloomberg.com - March 1 at 10:27 AM
finance.yahoo.com logoOlympus settles with Japan whistleblower after 8-year battle
finance.yahoo.com - February 18 at 2:34 AM
wsj.com logoFDA Approves Fixes for Olympus Scope Linked to Infections
www.wsj.com - January 17 at 7:57 PM
latimes.com logoOlympus to recall and redesign medical scope linked to superbug outbreaks
www.latimes.com - January 15 at 1:04 PM
bloomberg.com logoEx-Olympus CEO Woodford Sues Company for Breach of Contract
www.bloomberg.com - January 15 at 12:59 PM
bizjournals.com logo​Congressman wants SEC probe into Olympus over superbug outbreak
www.bizjournals.com - December 23 at 4:00 PM
finance.yahoo.com logoMedtronic-Samsung to Advance Neuromodulation Therapy
finance.yahoo.com - December 14 at 2:20 PM
finance.yahoo.com logoBecton, Dickinson Unveils BD FACSCelesta Flow Cytometer
finance.yahoo.com - December 14 at 1:20 PM
finance.yahoo.com logoSt. Jude Medical Unveils Positive Data from SUNBURST Study
finance.yahoo.com - December 14 at 1:10 PM
finance.yahoo.com logoFDA OKs Medtronic Activa DBS System for Full-Body MRI Scan
finance.yahoo.com - December 11 at 2:10 PM
finance.yahoo.com logoEdwards Lifesciences Reveals 2016 and Long-Term Outlook
finance.yahoo.com - December 10 at 2:15 PM
finance.yahoo.com logoathenahealth Unveils 2016 Outlook; 2015 Projections Intact
finance.yahoo.com - December 10 at 1:00 PM
finance.yahoo.com logoBecton, Dickinson IV Solution to Aid Medication Management
finance.yahoo.com - December 9 at 12:50 PM
finance.yahoo.com logoAllscripts (MDRX) Rides High on Partnerships, Customer Wins
finance.yahoo.com - December 8 at 9:50 AM
finance.yahoo.com logoCerner's HealtheIntent on a Roll: Wins a String of Contracts
finance.yahoo.com - December 7 at 4:45 PM
finance.yahoo.com logoSt. Jude Receives CE Mark for MRI on Quadra Assura CRT-D
finance.yahoo.com - December 7 at 4:05 PM
finance.yahoo.com logoCooper Companies Q4 Earnings, Revenues Lag; Stock Down
finance.yahoo.com - December 4 at 10:10 AM

Social

Olympus Corp (OCPNY) Chart for Tuesday, May, 23, 2017

This page was last updated on 5/23/2017 by MarketBeat.com Staff